48,985
edits
Line 113: | Line 113: | ||
The WHO GU Blue Book 5th Ed. recommends against subtyping. | The WHO GU Blue Book 5th Ed. recommends against subtyping. | ||
The defunct ''Type 1'' is papillary renal cell carcinoma. It is classically associated with a MET gene alteration. | |||
The defunct ''Type 2'' is a mix of | Where are 'Type 1' and 'Type 2': | ||
*The defunct ''Type 1'' is ''papillary renal cell carcinoma''. It is classically associated with a MET gene alteration. | |||
*The defunct ''Type 2'' is a mix of different RCCs, e.g. ALK-RCC, translocation RCC, FH-deficient RCC. | |||
Another subtype: | Another subtype: |
edits